UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Taxol ® : The First Microtubule Stabilizing Agent

International journal of molecular sciences, 2017-08, Vol.18 (8), p.1733

2017

Volltextzugriff (PDF)

Insulin-like Growth Factor 2 Expression Modulates Taxol Resistance and Is a Candidate Biomarker for Reduced Disease-Free Survival in Ovarian Cancer

Clinical cancer research, 2010-06, Vol.16 (11), p.2999-3010

2010

Volltextzugriff (PDF)

Targeting Protein Translation in Human Non-Small Cell Lung Cancer via Combined MEK and Mammalian Target of Rapamycin Suppression

Cancer research (Chicago, Ill.), 2007-12, Vol.67 (23), p.11300-11308

2007

Volltextzugriff (PDF)

Enhancement of the therapeutic efficacy of taxol by the mitogen-activated protein kinase kinase inhibitor CI-1040 in nude mice bearing human heterotransplants

Cancer research (Chicago, Ill.), 2005-04, Vol.65 (7), p.2854-2860

2005

Volltextzugriff (PDF)

Termination of Protofilament Elongation by Eribulin Induces Lattice Defects that Promote Microtubule Catastrophes

Current biology, 2016-07, Vol.26 (13), p.1713-1721

2016

Volltextzugriff (PDF)

Tissue microarray analysis of hormonal signaling pathways in uterine carcinosarcoma

American journal of obstetrics and gynecology, 2009-04, Vol.200 (4), p.457.e1-457.e5

2009

Volltextzugriff (PDF)

Mechanisms of Taxol resistance related to microtubules

Oncogene, 2003-10, Vol.22 (47), p.7280-7295

2003

Volltextzugriff (PDF)

Insights into the Mechanism of Microtubule Stabilization by Taxol

Proceedings of the National Academy of Sciences - PNAS, 2006-07, Vol.103 (27), p.10166-10173

2006

Volltextzugriff (PDF)

Expression of βV-Tubulin in Secretory Cells of the Fallopian Tube Epithelium Marks Cellular Atypia

International journal of gynecological cancer, 2018-02, Vol.28 (2), p.363-370

2018

Volltextzugriff (PDF)

TP53 hot spot mutations in ovarian cancer: Selective resistance to microtubule stabilizers in vitro and differential survival outcomes from The Cancer Genome Atlas

Gynecologic oncology, 2015-07, Vol.138 (1), p.159-164

2015

Volltextzugriff (PDF)

Design and Synthesis of (+)-Discodermolide–Paclitaxel Hybrids Leading to Enhanced Biological Activity

Journal of medicinal chemistry, 2011-09, Vol.54 (18), p.6319-6327

2011

Volltextzugriff (PDF)

Gene expression and mitotic exit induced by microtubule-stabilizing drugs

Cancer research (Chicago, Ill.), 2003-11, Vol.63 (22), p.7891-7899

2003

Volltextzugriff (PDF)

Reflections on My Life with Taxol

Cell, 2019-04, Vol.177 (3), p.502-505

Horwitz, Susan Band

2019

Volltextzugriff (PDF)

Exploiting MEK inhibitor-mediated activation of ERα for therapeutic intervention in ER-positive ovarian carcinoma

PloS one, 2013-02, Vol.8 (2), p.e54103

2013

Volltextzugriff (PDF)

Tubulin proteomics: Towards breaking the code

Analytical biochemistry, 2009-01, Vol.384 (2), p.197-206

2009

Volltextzugriff (PDF)

Synergistic suppression of microtubule dynamics by discodermolide and paclitaxel in non-small cell lung carcinoma cells

Cancer research (Chicago, Ill.), 2004-07, Vol.64 (14), p.4957-4964

2004

Volltextzugriff (PDF)

Phase I Clinical and Pharmacokinetic Study of BMS-247550, a Novel Derivative of Epothilone B, in Solid Tumors

Clinical cancer research, 2004-02, Vol.10 (4), p.1289-1298

2004

Volltextzugriff (PDF)

Correction: Exploiting MEK Inhibitor-Mediated Activation of ERα for Therapeutic Intervention in ER-Positive Ovarian Carcinoma

PloS one, 2016, Vol.11 (3), p.e0151750-e0151750

2016

Volltextzugriff (PDF)

Tumor Targeting by Covalent Conjugation of a Natural Fatty Acid to Paclitaxel

Clinical cancer research, 2001-10, Vol.7 (10), p.3229-3238

2001

Volltextzugriff (PDF)

Mechanism of action of taxol

Trends in pharmacological sciences (Regular ed.), 1992-04, Vol.13 (4), p.134-136

Band Horwitz, Susan

1992

Volltextzugriff (PDF)

A Common Pharmacophore for Cytotoxic Natural Products That Stabilize Microtubules

Proceedings of the National Academy of Sciences - PNAS, 1999-04, Vol.96 (8), p.4256-4261

1999

Volltextzugriff (PDF)

Personal Recollections on the Early Development of Taxol

Journal of natural products (Washington, D.C.), 2004-02, Vol.67 (2), p.136-138

Horwitz, Susan Band

2004

Volltextzugriff (PDF)

The Microtubule Stabilizing Agent Discodermolide is a Potent Inducer of Accelerated Cell Senescence

Cell cycle (Georgetown, Tex.), 2005-03, Vol.4 (3), p.501-507

2005

Volltextzugriff (PDF)

Selective Potentiation of Paclitaxel (Taxol)-Induced Cell Death by Mitogen-Activated Protein Kinase Kinase Inhibition in Human Cancer Cell Lines

Molecular pharmacology, 2001-08, Vol.60 (2), p.290-301

2001

Volltextzugriff (PDF)

Resistance to discodermolide, a microtubule-stabilizing agent and senescence inducer, is 4E-BP1-dependent

Proceedings of the National Academy of Sciences - PNAS, 2011-01, Vol.108 (1), p.391-396

2011

Volltextzugriff (PDF)

1 – 25 von 188

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(177)
Mit Volltextzugriff
(180)

Publikationsform

Sprache

Englisch
(188)

Erscheinungsjahr

n.n

Thema

Science & Technology
(126)
Life Sciences & Biomedicine
(111)
Humans
(79)
Animals
(74)
Biological And Medical Sciences
(55)
Oncology
(43)
Mice
(42)
Paclitaxel - Pharmacology
(42)
Biochemistry & Molecular Biology
(41)
Medical Sciences
(39)
Pharmacology. Drug Treatments
(35)
Antineoplastic Agents
(32)
Tubulin - Metabolism
(32)
Microtubules - Drug Effects
(29)
Microtubules - Metabolism
(26)
Antineoplastic Agents, Phytogenic - Pharmacology
(25)
Cell Line
(25)
Female
(25)
Cell Biology
(24)
Molecular Sequence Data
(24)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Taxol ® : The First Microtubule Stabilizing Agent

Insulin-like Growth Factor 2 Expression Modulates Taxol Resistance and Is a Candidate Biomarker for Reduced Disease-Free Survival in Ovarian Cancer

Targeting Protein Translation in Human Non-Small Cell Lung Cancer via Combined MEK and Mammalian Target of Rapamycin Suppression

Enhancement of the therapeutic efficacy of taxol by the mitogen-activated protein kinase kinase inhibitor CI-1040 in nude mice bearing human heterotransplants

Termination of Protofilament Elongation by Eribulin Induces Lattice Defects that Promote Microtubule Catastrophes

Tissue microarray analysis of hormonal signaling pathways in uterine carcinosarcoma

Mechanisms of Taxol resistance related to microtubules

Insights into the Mechanism of Microtubule Stabilization by Taxol

Expression of βV-Tubulin in Secretory Cells of the Fallopian Tube Epithelium Marks Cellular Atypia

TP53 hot spot mutations in ovarian cancer: Selective resistance to microtubule stabilizers in vitro and differential survival outcomes from The Cancer Genome Atlas

Design and Synthesis of (+)-Discodermolide–Paclitaxel Hybrids Leading to Enhanced Biological Activity

Gene expression and mitotic exit induced by microtubule-stabilizing drugs

Reflections on My Life with Taxol

Exploiting MEK inhibitor-mediated activation of ERα for therapeutic intervention in ER-positive ovarian carcinoma

Tubulin proteomics: Towards breaking the code

Synergistic suppression of microtubule dynamics by discodermolide and paclitaxel in non-small cell lung carcinoma cells

Phase I Clinical and Pharmacokinetic Study of BMS-247550, a Novel Derivative of Epothilone B, in Solid Tumors

Correction: Exploiting MEK Inhibitor-Mediated Activation of ERα for Therapeutic Intervention in ER-Positive Ovarian Carcinoma

Tumor Targeting by Covalent Conjugation of a Natural Fatty Acid to Paclitaxel

Mechanism of action of taxol

A Common Pharmacophore for Cytotoxic Natural Products That Stabilize Microtubules

Personal Recollections on the Early Development of Taxol

The Microtubule Stabilizing Agent Discodermolide is a Potent Inducer of Accelerated Cell Senescence

Selective Potentiation of Paclitaxel (Taxol)-Induced Cell Death by Mitogen-Activated Protein Kinase Kinase Inhibition in Human Cancer Cell Lines

Resistance to discodermolide, a microtubule-stabilizing agent and senescence inducer, is 4E-BP1-dependent

Suchergebnisse filtern